Biblio

Export 366 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is C  [Clear All Filters]
2017
S. Wolfsgruber, Polcher, A., Koppara, A., Kleineidam, L., Frölich, L., Peters, O., Hüll, M., Rüther, E., Wiltfang, J., Maier, W., Kornhuber, J., Lewczuk, P., Jessen, F., and Wagner, M., “Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 3, pp. 939-950, 2017.
G. P. Paraskevas, Kasselimis, D., Kourtidou, E., Constantinides, V., Bougea, A., Potagas, C., Evdokimidis, I., and Kapaki, E., “Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1453-1461, 2017.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., “Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”, J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
A. Rivero-Santana, Ferreira, D., Perestelo-Pérez, L., Westman, E., Wahlund, L. - O., Sarría, A., and Serrano-Aguilar, P., “Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.”, J Alzheimers Dis, vol. 55, no. 2, pp. 625-644, 2017.
S. Lista, Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., Cavedo, E., Santos, A. Melo Dos, Epelbaum, S., Lamari, F., Dubois, B., Nisticò, R., Floris, R., Garaci, F., and Hampel, H., “Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1327-1334, 2017.
E. T. Ighodaro, Nelson, P. T., Kukull, W. A., Schmitt, F. A., Abner, E. L., Caban-Holt, A., Bardach, S. H., Hord, D. C., Glover, C. M., Jicha, G. A., Van Eldik, L. J., Byrd, A. X., and Fernander, A., “Challenges and Considerations Related to Studying Dementia in Blacks/African Americans.”, J Alzheimers Dis, vol. 60, no. 1, pp. 1-10, 2017.
I. Apostolova, Lange, C., Roberts, A., Igel, H. Joachim, Mäurer, A., Liese, S., Estrella, M., Prasad, V., Stechl, E., Lämmler, G., Steinhagen-Thiessen, E., and Buchert, R., “Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients.”, J Alzheimers Dis, vol. 56, no. 1, pp. 197-204, 2017.
D. P. Devanand, Lentz, C., Chunga, R. E., Ciarleglio, A., Scodes, J. M., Andrews, H., Schofield, P. W., Stern, Y., Huey, E. D., Bell, K., and Pelton, G. H., “Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1525-1531, 2017.
L. Crispoltoni, Stabile, A. Maria, Pistilli, A., Venturelli, M., Cerulli, G., Fonte, C., Smania, N., Schena, F., and Rende, M., “Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1005-1017, 2017.
H. Yin, Wang, W., Yu, W., Li, J., Feng, N., Wang, L., and Wang, X., “Changes in Synaptic Plasticity and Glutamate Receptors in Type 2 Diabetic KK-Ay Mice.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1207-1220, 2017.
P. Majerova, Barath, P., Michalicova, A., Katina, S., Novak, M., and Kovac, A., “Changes of Cerebrospinal Fluid Peptides due to Tauopathy.”, J Alzheimers Dis, vol. 58, no. 2, pp. 507-520, 2017.
S. C. C. Chan, Chan, C. C. H., Derbie, A. Y., Hui, I., Tan, D. G. H., Pang, M. Y. C., Lau, S. C. L., and Fong, K. N. K., “Chinese Calligraphy Writing for Augmenting Attentional Control and Working Memory of Older Adults at Risk of Mild Cognitive Impairment: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 58, no. 3, pp. 735-746, 2017.
M. T. Turnbull and Coulson, E. J., “Cholinergic Basal Forebrain Lesion Decreases Neurotrophin Signaling without Affecting Tau Hyperphosphorylation in Genetically Susceptible Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1141-1154, 2017.
T. Matsuda and Hisatsune, T., “Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AβPPswe/PSEN1dE9 Alzheimer's Disease Model Mice Fed a High-Fat Diet.”, J Alzheimers Dis, vol. 56, no. 1, pp. 1-23, 2017.
D. E. Moss, Perez, R. G., and Kobayashi, H., “Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1285-1294, 2017.
V. Vasquez, Mitra, J., Hegde, P. M., Pandey, A., Sengupta, S., Mitra, S., Rao, K. S., and Hegde, M. L., “Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease.”, J Alzheimers Dis, 2017.
F. Gelfo, Cutuli, D., Nobili, A., De Bartolo, P., D'Amelio, M., Petrosini, L., and Caltagirone, C., “Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1505-1518, 2017.
L. Caspar Thygesen, Gimsing, L. N. Ørreslet, Bautz, A., Hvidt, N. Christian, and Johansen, C., “Chronic Neurodegenerative Illnesses and Epilepsy in Danish Adventists and Baptists: A Nationwide Cohort Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1429-1435, 2017.
S. Villarreal, Zhao, F., Hyde, L. A., Holder, D., Forest, T., Sondey, M., Chen, X., Sur, C., Parker, E. M., and Kennedy, M. E., “Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1393-1413, 2017.
L. L. Law, Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., N Dowling, M., Gallagher, C. L., Bendlin, B. B., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A., Johnson, S. C., Cook, D. B., Stein, J. H., and Okonkwo, O. C., “Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 351-359, 2017.
P. Gareri, Castagna, A., Cotroneo, A. Maria, Putignano, D., Conforti, R., Santamaria, F., Marino, S., and Putignano, S., “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.
I. Beheshti, Maikusa, N., Daneshmand, M., Matsuda, H., Demirel, H., and Anbarjafari, G., “Classification of Alzheimer's Disease and Prediction of Mild Cognitive Impairment Conversion Using Histogram-Based Analysis of Patient-Specific Anatomical Brain Connectivity Networks.”, J Alzheimers Dis, vol. 60, no. 1, pp. 295-304, 2017.
D. G. Amen, Krishnamani, P., Meysami, S., Newberg, A., and Raji, C. A., “Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging.”, J Alzheimers Dis, vol. 57, no. 1, pp. 253-266, 2017.
M. Isserles, Daskalakis, Z. J., Kumar, S., Rajji, T. K., and Blumberger, D. M., “Clinical Effectiveness and Tolerability of Electroconvulsive Therapy in Patients with Neuropsychiatric Symptoms of Dementia.”, J Alzheimers Dis, vol. 57, no. 1, pp. 45-51, 2017.
L. F. J. R. Miranda, Gomes, K. B., Tito, P. A. L., Silveira, J. N., Pianetti, G. A., Byrro, R. M. D., Peles, P. R. H., Pereira, F. H., Santos, T. R., Assini, A. G., Ribeiro, V. V., Moraes, E. N., and Caramelli, P., “Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.”, J Alzheimers Dis, vol. 55, no. 2, pp. 539-549, 2017.

Pages